Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP.

K-Number: K810427 · 1981-03-31

ApplicantPfizer Pharmaceuticals
Decision Date1981-03-31
Product CodeJTN
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP. is the device name listed in this FDA 510(k) record. The listed applicant is Pfizer Pharmaceuticals. It received FDA 510(k) clearance on 1981-03-31 under 510(k) number K810427. The device is classified under product code JTN. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP.?

CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP. is a medical device that received FDA 510(k) clearance on 1981-03-31. The listed applicant is Pfizer Pharmaceuticals. The 510(k) number is K810427.

When did CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP. receive FDA 510(k) clearance?

CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP. received FDA 510(k) clearance on 1981-03-31, under 510(k) number K810427.

Who is the listed applicant for CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP.?

The FDA 510(k) record lists Pfizer Pharmaceuticals as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP.?

The FDA product code for CEFOTAXIME 30MCG ANTIMICROBIAL SUSCEP. is JTN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Pfizer Pharmaceuticals as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K885321WATER JEL STERILE GEL-SOAKED BURN DRESSINGK802408E-VAC BLOOD CULTURE SYSTEMK771605CREATINE KINASE ISOENZYME SUBSTRATE SETK770801MICROBIO. PROD. FLUORESCENT ANTIBODYK770425NEEDLES, STERILE, AIRWAY

Related Devices (Code: JTN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262113HardyDisk AST Tebipenem 10µg (TBP10)Hardy DiagnosticsK261781Thermo Scientific Oxoid Cefepime/Zidebactam Disc (30/30 µg) FPZ60Thermo Fisher Scientific (Oxoid Ltd.)K261853Gepotidacin GEP 10 µgLiofilchem, Inc.K260842HardyDisk AST Gepotidacin 10µg (GEP10)Hardy DiagnosticsK251337Thermo Scientific Oxoid Gepotidacin Disc (10 µg) GEP10Thermo Fisher Scientific (Oxoid Ltd.)K253105HardyDisk AST Cefiderocol 30µg (FDC30)Hardy Diagnostics

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑